Company Financials

Xenon Pharmaceuticals Inc. Financials

United States dollar

business Xenon Pharmaceuticals Inc. Company Profile

Main Stock Listing

NASDAQ: XENE

Market Capitalization $3.44 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -14.78
Forward PE -9.74
Price to Sales TTM $458.40
Price to Book MRQ $6.13
Enterprise to Revenue 397.87
Enterprise to EBITDA -8.82

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.00%
Operating Margin -4543.73%
Return on Assets TTM -29.51%
Return on Equity TTM -45.14%

Income Statement

Revenue TTM $7,500,000
Revenue per Share TTM $0.10
Quarterly Revenue Growth %
Gross Profit TTM $-265,211,008
EBITDA $-338,182,016
Net Income to Common TTM $-306,334,016
Diluted EPS TTM $-3.89
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $462,268,000
Total Cash per Share MRQ $5.98
Total Debt MRQ $
Total Debt to Equity MRQ 1.49
Current Ratio MRQ 12.53
Book Value per Share MRQ $7.26

Cash Flow

Operating Cash Flow TTM $-252,022,000
Levered Free Cash Flow TTM $-162,175,504

XENE Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 77,120,168
Float Shares 71,790,025
Avg 10 Volume 732,250
Avg 30 Volume None
Shares Short 5,720,672
Short Ratio 7.04
Short % of Shares 8.25%
% Held by Insiders 0.11%
% Held by Institutions 112.56%

Stock Price Summary

Beta 1.03
Fifty Two Week Low $26.74
Fifty Two Week High $46.60
Fifty Two Week Change 8.47%
Day 50 MA $42.43
Day 200 MA $36.57

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date